organophosphonates has been researched along with epidermal growth factor in 5 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 24,155 | 217 | 4,699 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carel, K; Draznin, B; Goalstone, M; Kline, T; Leitner, JW | 1 |
| Burda, MR; Dandri, M; Petersen, J; Will, H | 1 |
| Hirayama, R; Inoue, T; Inoue, Y; Ishibushi, E; Ito, Y; Kirii, Y; Kiyoi, T; Kondo, H; Kumihara, H; Kurokawa, K; Maeda, Y; Miyasaka, T; Nishiwaki, E; Ohmoto, H; Sawa, M; Yamamoto, M; Yoshino, K | 1 |
| Cowan, MJ; Gladwin, MT; Huang, XL; Logun, C; Madara, P; Pawliczak, R; Shelhamer, JH | 1 |
| Haar Petersen, M; Huang, H; Ibañez-Vea, M; Larsen, MR; Lassen, PS; Palmisano, G | 1 |
5 other study(ies) available for organophosphonates and epidermal growth factor
| Article | Year |
|---|---|
Hyperinsulinemia potentiates activation of p21Ras by growth factors.
Topics: 3T3 Cells; Alkyl and Aryl Transferases; Animals; Drug Synergism; Enzyme Inhibitors; Epidermal Growth Factor; Farnesol; Farnesyltranstransferase; Growth Substances; Guanosine Triphosphate; Insulin; Insulin-Like Growth Factor I; Mice; Organophosphonates; Organophosphorus Compounds; Protein Prenylation; Proto-Oncogene Proteins p21(ras); Transferases | 1997 |
Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA.
Topics: Adenine; Animals; Antiviral Agents; Cells, Cultured; DNA, Circular; DNA, Viral; Epidermal Growth Factor; Hepatitis B Virus, Woodchuck; Liver; Marmota; Organophosphonates; Virus Replication | 2000 |
New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.
Topics: Amides; Crystallography, X-Ray; Epidermal Growth Factor; Heparin-binding EGF-like Growth Factor; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Models, Molecular; Organophosphonates; Protease Inhibitors; Protein Binding; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
Epidermal growth factor induces p11 gene and protein expression and down-regulates calcium ionophore-induced arachidonic acid release in human epithelial cells.
Topics: Annexin A2; Arachidonic Acid; Arachidonic Acids; Calcimycin; Calcium; Calcium-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Epidermal Growth Factor; Epithelial Cells; ErbB Receptors; HeLa Cells; Humans; Ionophores; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Organophosphonates; Phospholipases A; Phosphorylation; Recombinant Proteins; S100 Proteins | 2002 |
Simultaneous Enrichment of Cysteine-containing Peptides and Phosphopeptides Using a Cysteine-specific Phosphonate Adaptable Tag (CysPAT) in Combination with titanium dioxide (TiO2) Chromatography.
Topics: Chromatography, Liquid; Cysteine; Epidermal Growth Factor; ErbB Receptors; HeLa Cells; Humans; Isotope Labeling; Organophosphonates; Peptides; Phosphopeptides; Phosphorylation; Proteomics; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Titanium | 2016 |